GlobeStar Therapeutics Corp (GSTC)

[BluePineCapital]

I would like to believe so, but there is just not much room for movement at this level. A bio company needs money, they do not have a product to sell at the moment. We will be a $0 revenue company for years to come and share price will be based on forward potential earnings.

There will be more shares converted in May and you better believe more notes were taken out in Q1 and most likely this Quarter as well so there will be more dilution in the summer months and then into the fall.

A CRO will not take this on without cash up front and the last filing shows about $0 in the bank.

There is no more room for toxic lenders at this level, so the only logical reasoning would be a reverse split (lets say a 1:25 or even a 1:50) would get the PPS in the low pennies and then start the funding routine all over again.

I hope I am wrong, but logic points to that direction unless management hires a magician and pulls a rabbit out of a hat.